% Expired Patents = 75.0

CIPO Patents = 1

EPO Patents = 1

Forward Citations = 24

Loading Chart...

10 inventors (with patents filed for the assignee):

Rinaldo Zurbriggen (3 out of 10 patents)

Mario Amacker (2 out of 4 patents)

Silvia Rasi (2 out of 3 patents)

4. Andreas Kammer (2 out of 3 patents)

5. Flavia De Bernardis (1 out of 4 patents)

6. Antonio Cassone (1 out of 10 patents)

7. Thomas Grunwald (1 out of 1 patent)

8. Klaus Ueberla (1 out of 1 patent)

9. Christian Moser (1 out of 1 patent)

10. Nicole Westerfeld (1 out of 1 patent)

11. Thomas Grunwald (0 patent)

4 patents: Sort by Forward Citations

1. 8852604 - Multiepitope vaccine for Her2/neu-associated cancers (2014-10-07),

2. 8715698 - Truncated secretory aspartyl proteinase 2 (2014-05-06),

3. 8372963 - RSV F-protein and its use (2013-02-12),

4. 8367077 - Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof (2013-02-05),

Company Overview

Pevion Biotech Ag is a Swiss biotechnology company focused on developing innovative vaccines for infectious diseases and cancer. With a strong emphasis on research and development, Pevion strives to provide safe and effective solutions to improve global health. The company's cutting-edge technology and experienced team have positioned it as a leader in the field of biopharmaceuticals.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

4 Patents

#1 in Ittigen

#2,006 in Switzerland

Ittigen, Switzerland

Pevion Biotech Ag

Forward Citations = 24

10 inventors:

Rinaldo Zurbriggen (3 out of 10 patents)

Mario Amacker (2 out of 4 patents)

Silvia Rasi (2 out of 3 patents)

4. Andreas Kammer (2 out of 3 patents)

5. Flavia De Bernardis (1 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Pevion Biotech Ag. Retrieved from https://idiyas.com/company/pevion-biotech-ag

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]